Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents
- 1 March 1998
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 22 (3) , 221-239
- https://doi.org/10.1016/s0145-2126(97)00174-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Measurement of Spontaneous and Therapeutic Agent-Induced Apoptosis With BCL-2 Protein Expression in Acute Myeloid LeukemiaBlood, 1997
- UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53JNCI Journal of the National Cancer Institute, 1996
- Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2Journal of Biological Chemistry, 1996
- BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agentsBlood, 1995
- p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignanciesBlood, 1994
- Analysis of p53 gene mutations in acute myeloid leukemiaAmerican Journal of Hematology, 1994
- Apoptotic Cell Death During Treatment of LeukemiasLeukemia & Lymphoma, 1994
- Immunophenotyping of Acute Leukemia by Flow Cytometric Analysis:Use of CD45 and Right-Angle Light Scatter to Gate on Leukemic Blasts in Three-Color AnalysisAmerican Journal of Clinical Pathology, 1993
- Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS)Annals of Hematology, 1993
- Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometryBritish Journal of Cancer, 1989